Share Email Print
cover

Proceedings Paper

Identifying incremental costs for successive generations of implantable cardiac pacemakers
Author(s): Allen A. Hughes
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

This paper provides an assessment of the incremental expected costs of increasingly sophisticated generations of cardiac pacemaker technology. A decision analytic framework is used to calculate expected costs of pacemaker therapy over a five-year period, taking into account failure rate estimates for the various generations, device replacement costs, hospital fees, physician's fees, follow-up care, and patient lost time in follow-up care. For five years of pacing therapy, the incremental cost difference between nonprogrammable and multiprogrammable is $1887; between multiprogrammable and dual-chamber is $3321; and between dual-chamber and dual-chamber rate-responsive is $676. Incremental benefits were found extremely difficult to quantify, monetarize, or translate to a scale for comparison with costs. However, medical literature indicates a decreasing level of risk for mortality and morbidity, owing to increased hemodynamic benefits from the more recent generations of high technology pacemakers.

Paper Details

Date Published: 6 December 1994
PDF: 14 pages
Proc. SPIE 2307, Health Care Technology Policy I: The Role of Technology in the Cost of Health Care, (6 December 1994); doi: 10.1117/12.195486
Show Author Affiliations
Allen A. Hughes, George Mason Univ. (United States)


Published in SPIE Proceedings Vol. 2307:
Health Care Technology Policy I: The Role of Technology in the Cost of Health Care

© SPIE. Terms of Use
Back to Top